Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Moderna, Inc. - Common Stock (NQ:MRNA)

29.49 -0.92 (-3.03%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Moderna, Inc. - Common Stock

< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
News headline image
US Stocks Likely To Open In Red After Jerome Powell Says No Need To Be 'In A Hurry' On Rate Cuts: Tesla, TSMC And Domino's In Focus ↗
U.S. stocks could open on a negative note on Friday after the Federal Reserve chair Jerome Powell's comments on Thursday that the economy is showing enough strength that there is no need to be "in a... 
Via Benzinga
Topics Economy
News headline image
Palantir, Moderna, Pfizer, Alibaba, Tesla: Why These 5 Stocks Are On Investors' Radars Today ↗
US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by nearly 0.6% respectively. 
Via Benzinga
Topics Stocks
News headline image
Trump Taps RFK Jr. For Health Secretary Role, Sends 5 Vaccine Stocks Lower ↗
Trump may appoint Robert F. Kennedy Jr. as HHS Secretary, stirring mixed reactions. Kennedy's views on vaccines could reshape policies and affect vaccine stocks. 
Via Benzinga
Topics Government
News headline image
The Oncology Bet Is Already Paying Off For Pfizer ↗
With the downfall of Covid-19, pharmaceutical companies turned to oncology in search for their next growth story. Earlier in October, Pfizer Inc (NYSE: PFE) reported its third quarter revenue grew 14%... 
Via Benzinga
News headline image
Smart Money Is Betting Big In MRNA Options ↗
 
Via Benzinga
News headline image
Moderna Receives Health Canada Approval for RSV Vaccine for Adults Aged 60 Years and Older
Via ACCESSWIRE
News headline image
Moderna Reports Third Quarter 2024 Financial Results and Provides Business Updates
Via ACCESSWIRE
News headline image
Bird Flu Puts Teen In Critical Condition As Canada Reports First Human Case: What You Need To Know ↗
Pfizer and Moderna are hustling to develop an mRNA bird flu vaccine, the same technology used in the companies' respective COVID-19 vaccines. 
Via Benzinga
News headline image
Moderna Tops BioSpace's Best Places to Work Ranking for Fourth Consecutive Year
Via ACCESSWIRE
News headline image
The Week Kamala Harris Lost (Nov 4-8), These Large Cap Stocks Lost Big ↗
Kamala Harris lost 2024 US election, 10 large-cap stocks performed poorly: Moderna, Honda, Akamai, ADS, AstraZeneca, Pinterest, MercadoLibre, First Solar, POSCO, Floor & Decor 
Via Benzinga
News headline image
Moderna's Q3 Earnings Beat Overshadowed By Vaccine Demand Slowdown And Market Share Concerns, Analysts Warn ↗
Moderna's stock faces a decline as analysts lower the price target to $90, citing weaker vaccine demand and concerns over upcoming COVID and RSV sales. 
Via Benzinga
Topics Earnings
News headline image
2 Biotech Stocks You Can Buy Hand Over Fist This Month ↗
Both stocks have made significant breakthroughs. 
Via The Motley Fool
News headline image
If You Invested $100 In This Stock 5 Years Ago, You Would Have $300 Today ↗
 
Via Benzinga
News headline image
In-Depth Examination Of 15 Analyst Recommendations For Moderna ↗
 
Via Benzinga
News headline image
Moderna to Present at Upcoming Conferences in November 2024
Via ACCESSWIRE
News headline image
Trump's Potential 'Health Czar' Robert F. Kennedy Jr. Rattles Vaccine Stocks: 'Shoot First Reaction' ↗
Donald Trump has said he will give Robert F. Kennedy Jr. a senior role in his incoming administration to advance his "Make America Healthy Again" agenda. 
Via Benzinga
Topics Government
News headline image
Moderna (MRNA) Q3 2024 Earnings Call Transcript ↗
MRNA earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
Moderna Q3 Revenue Beats On Updated COVID-19 Vaccine, Slashes Expenses For 2024 ↗
Moderna stock rises as Q3 revenue beats estimates at $1.83 billion, driven by strong U.S. COVID-19 vaccine sales. EPS of $0.03 exceeds expectations. 
Via Benzinga
News headline image
Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing? ↗
The company reported just $10 million in sales of its RSV vaccine, mResvia, widely missing expectations. 
Via Investor's Business Daily
News headline image
Moderna Gears Up For Q3 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts ↗
 
Via Benzinga
News headline image
Behind the Scenes of Moderna's Latest Options Trends ↗
 
Via Benzinga
News headline image
Cathie Wood's Wednesday Exodus: Moderna And Jack Dorsey's Block Stocks Get Dumped ↗
On Wednesday, Ark Invest, led by Cathie Wood, made significant trades in Moderna Inc. (NASDAQ:MRNA) and Square Inc. (NYSE:SQ). The Moderna Trade 
Via Benzinga
News headline image
Trump Has Asked Me To Do 3 Things, Says Robert Kennedy Jr. ↗
Robert Kennedy Jr. revealed Trump's directive to tackle health agency corruption, promote science, and end chronic disease. 
Via Benzinga
Topics Government
News headline image
These Are the 5 Worst-Performing Stocks in the S&P 500 With 2024 Almost Over ↗
Perhaps this list is a good place to start bargain-hunting. 
Via The Motley Fool
Topics Stocks
News headline image
Is It Time to Buy October's Worst-Performing Nasdaq Stocks? ↗
Is it a good time to scoop up last month's biggest losers? Check out October's largest price drops on the Nasdaq, and see whether any of them look like good buys today. 
Via The Motley Fool
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
2 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
These are the kinds of stocks that can allow investors to sleep easy at night. 
Via The Motley Fool
News headline image
These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could The Trend Continue If Harris Wins 2024 Election? ↗
A look at the top 10 performing S&P 500 stocks in 2021 could point to trends to watch if Kamala Harris wins the 2024 election. 
Via Benzinga
Topics Stocks
News headline image
Why Is Moderna Stock Trading Higher On Monday? ↗
Merck and Moderna initiate Phase 3 trial of mRNA-4157 (V940) with Keytruda as adjuvant for NSCLC patients, marking progress in individualized cancer therapies. 
Via Benzinga
News headline image
Merck and Moderna Initiate Phase 3 Trial Evaluating Adjuvant V940 (mRNA-4157) in Combination with KEYTRUDA® (pembrolizumab) After Neoadjuvant KEYTRUDA and Chemotherapy in Patients With Certain Types of Non-Small Cell Lung Cancer (NSCLC)
From Merck & Co., Inc.
Via Business Wire
< Previous 1 2
...
21 22 23 24 25 26 27 28 29
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.